Skip to Content
Merck
  • 27-hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages.

27-hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages.

Biochemical and biophysical research communications (2012-12-19)
Sun-Mi Kim, Hyojung Jang, Yonghae Son, Sae-A Lee, Sun-Sik Bae, Young Chul Park, Seong-Kug Eo, Koanhoi Kim
ABSTRACT

Enhanced production of TNF-α from macrophages promotes development and instability of atherosclerotic plaques, but involvement of lipid component in TNF-α production has not been clarified in atherosclerosis. We attempted to determine whether cholesterol oxidation products (oxysterols) could modify TNF-α production. Treatment of THP-1 cells with 27-hydroxycholesterol (27OHChol) or 7α-hydroxycholesterol (7αOHChol) resulted in a profound increase in TNF-α transcription, while treatment with an identical concentration of cholesterol and 7-ketochoelsterol did not lead to any change in TNF-α expression. Treatment with 27OHChol resulted in increased synthesis, as well as secretion, of TNF-α, while 7αOHChol led to increased synthesis of TNF-α without affecting secretion of the cytokine. Co-treatment with 7αOHChol or 27OHChol and LPS resulted in synergistically enhanced or augmented secretion of TNF-α. Treatment with TO-901317, pertussis toxin, PP2, and LY294002 resulted not only in attenuated transcription of TNF-α induced by 27OHChol and 7αOHChol, but also secretion of TNF-α enhanced by 27OHChol. This is the first report demonstrating enhanced production of TNF-α in macrophages by treatment with oxysterols which are detected in abundance in atheromatous lesions; in addition, results of the current study provide evidence indicating that certain types of oxysterols contribute to development of atherosclerosis by promoting production of proinflammatory cytokines.

MATERIALS
Product Number
Brand
Product Description

Avanti
27-hydroxycholesterol, Avanti Research - A Croda Brand